跳至主要内容
临床试验/JPRN-jRCT1070220018
JPRN-jRCT1070220018进行中(未招募)2 期

Efficacy and Safety of Hot Spring Water 99 of Blood Glucose and Intestinal Variability: An Open Randomized Placebo-Controlled Two-sequence Two-Phase Crossover Phase IIb Study

Ohishi Mitsuru0 个研究点目标入组 20 人开始时间: 2022年6月21日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • 1) Patients providing written informed and consent to participate in the study.
  • 2) Aged >= 20 years (irrespective of sex).
  • 3) Patients with HbA1c levels in the boundary range(5.6-6.4%).

排除标准

  • 1) Patients who have taken, or plan to take during this study, medications that may affect this study (antiallergic drugs, bowel preparations, laxatives, etc.) since the pre- test.
  • 2) Patients who regularly use medicines for diabetes.
  • 3) Patients who have taken antibiotics before one month prior to the start of drinking water for study, or plan to do so during this study period.
  • 4) Patients who have been using food for specified health uses, functional foods, supplements, or health foods that may affect this study for more than 3 days a week prior to participation in this study.
  • 5) Patients with a history of appendicectomy.
  • 6) Patients who have undergone surgery that may affect the test within six months prior to the date of the pre-test (colonoscopy, removal of gallstones or gall bladder, gastric bypass surgery, etc.)
  • 7) Heavy drinkers of alcohol.
  • 8) Patients with extremely irregular dietary habits or irregular rhythms of life (shift workers, late-night workers, etc.)
  • 9) Patients who are during participating in a clinical trial of another drug or health food, or who plan to participate in another clinical trial within 4 weeks after the completion of this trial or after consenting to participate in this trial.
  • 10) Pregnant women, those who plan or may become pregnant, and those who are breastfeeding.
  • 11) Patients with a history or current history of serious diseases of the heart, liver, kidney, digestive organs, etc.
  • 12) Patients with allergies to medicines or food.
  • 13) Patients who have donated component blood or 200mL whole blood for the month prior to the screening test.
  • 14) Men who donated 400 mL of whole blood for 3 months prior to the screening test.
  • 15) Women who donated 400 mL of whole blood for 4 months prior to the screening test.
  • 16) Men whose blood collection volume from 12 months prior to the screening test plus the total planned blood collection volume for this study exceeds 1200 mL.
  • 17) Women whose blood collection volume from 12 months prior to the screening test plus the total planned blood collection volume for this study exceeds 800 mL.
  • 18) Employees of SOC Corporation and their families.
  • 19) Patinets who are judged inappropriate to participate in this study by the principal investigator or sub-investigator.

研究者

发起方
Ohishi Mitsuru

相似试验